Literature DB >> 23394931

Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells.

Chenzi Yang1, Yuanyuan Guo, Caroline C Jadlowiec, Xin Li, Wei Lv, Lynn S Model, Michael J Collins, Yuka Kondo, Akihito Muto, Chang Shu, Alan Dardik.   

Abstract

BACKGROUND: During vein graft adaptation to the arterial circulation, vascular endothelial growth factor (VEGF) A expression transiently increases before becoming downregulated; however, the role of VEGF-A in venous remodeling is not clear. In addition, although VEGF-A stimulates angiogenesis and determines arterial identity in nascent arterial endothelial cells (EC), the role of VEGF-A in regulating identity in adult venous EC is also not clear.
MATERIALS AND METHODS: EC, wild type (EphB4+/+) or heterozygous knockout (EphB4+/-), were stimulated with VEGF-A (0-100 ng/mL) and examined with quantitative polymerase chain reaction and western blotting.
RESULTS: VEGF-A (100 ng/mL) inhibited expression of EphB4 and stimulated expression of delta-like ligand 4 (dll4) but did not stimulate either notch or EphrinB2 expression in adult venous EC. Pretreatment with VEGF receptor 2-neutralizing antibody abolished VEGF-stimulated downregulation of EphB4 but not the upregulation of dll4. Pretreatment with PD98059 or wortmannin showed that VEGF-A downregulation of EphB4 and upregulation of dll4 are mitogen-activated protein kinase kinase and extracellular signal-regulated kinase dependent but phosphatidylinositol 3 kinase-Akt independent. Compared with VEGF-induced EphB4 downregulation and dll4 upregulation in control EC, reduced EphB4 signaling in EphB4+/- EC showed even further downregulation of EphB4 and upregulation of dll4.
CONCLUSIONS: Despite the genetic programming of arterial and venous EC fate, VEGF-A can repress venous identity in adult venous EC without induction of arterial identity. These changes in adult EC in vitro recapitulate the changes in identity described during vein graft adaptation to the arterial environment in vivo. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23394931      PMCID: PMC3661748          DOI: 10.1016/j.jss.2013.01.009

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  44 in total

Review 1.  An overview of the Notch signalling pathway.

Authors:  Martin Baron
Journal:  Semin Cell Dev Biol       Date:  2003-04       Impact factor: 7.727

2.  Gene expression changes evoked in a venous segment exposed to arterial flow.

Authors:  Deborah Abeles; Stephanie Kwei; George Stavrakis; Yuzhi Zhang; Eric T Wang; Guillermo García-Cardeña
Journal:  J Vasc Surg       Date:  2006-10       Impact factor: 4.268

3.  The range of adaptation by collateral vessels after femoral artery occlusion.

Authors:  Inka Eitenmüller; Oscar Volger; Alexander Kluge; Kerstin Troidl; Miroslav Barancik; Wei-Jun Cai; Matthias Heil; Frederic Pipp; Silvia Fischer; Anton J G Horrevoets; Thomas Schmitz-Rixen; Wolfgang Schaper
Journal:  Circ Res       Date:  2006-08-24       Impact factor: 17.367

4.  EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.

Authors:  Injune Kim; Young Shin Ryu; Hee Jin Kwak; So Young Ahn; Jong-Lark Oh; George D Yancopoulos; Nicholas W Gale; Gou Young Koh
Journal:  FASEB J       Date:  2002-05-21       Impact factor: 5.191

Review 5.  Specification of arterial, venous, and lymphatic endothelial cells during embryonic development.

Authors:  Tsutomu Kume
Journal:  Histol Histopathol       Date:  2010-05       Impact factor: 2.303

6.  ERK1/2-Akt1 crosstalk regulates arteriogenesis in mice and zebrafish.

Authors:  Bin Ren; Yong Deng; Arpita Mukhopadhyay; Anthony A Lanahan; Zhen W Zhuang; Karen L Moodie; Mary Jo Mulligan-Kehoe; Tatiana V Byzova; Randall T Peterson; Michael Simons
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

7.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

Review 8.  Arterial-venous specification during development.

Authors:  Matthew R Swift; Brant M Weinstein
Journal:  Circ Res       Date:  2009-03-13       Impact factor: 17.367

9.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.

Authors:  N W Gale; P Baluk; L Pan; M Kwan; J Holash; T M DeChiara; D M McDonald; G D Yancopoulos
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

10.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

View more
  9 in total

Review 1.  Molecular identity of arteries, veins, and lymphatics.

Authors:  Katharine Wolf; Haidi Hu; Toshihiko Isaji; Alan Dardik
Journal:  J Vasc Surg       Date:  2018-08-25       Impact factor: 4.268

2.  Coculture of stem cells from apical papilla and human umbilical vein endothelial cell under hypoxia increases the formation of three-dimensional vessel-like structures in vitro.

Authors:  Changyong Yuan; Penglai Wang; Lifang Zhu; Waruna Lakmal Dissanayaka; David William Green; Edith H Y Tong; Lijian Jin; Chengfei Zhang
Journal:  Tissue Eng Part A       Date:  2014-12-23       Impact factor: 3.845

3.  Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.

Authors:  Daniel J Wong; Daniel Y Lu; Clinton D Protack; Go Kuwahara; Hualong Bai; Nirvana Sadaghianloo; George Tellides; Alan Dardik
Journal:  J Vasc Surg       Date:  2014-10-24       Impact factor: 4.268

4.  Eph-B4 mediates vein graft adaptation by regulation of endothelial nitric oxide synthase.

Authors:  Mo Wang; Michael J Collins; Trenton R Foster; Hualong Bai; Takuya Hashimoto; Jeans M Santana; Chang Shu; Alan Dardik
Journal:  J Vasc Surg       Date:  2016-01-24       Impact factor: 4.268

5.  Endovascular biopsy: Strategy for analyzing gene expression profiles of individual endothelial cells obtained from human vessels.

Authors:  Zhengda Sun; Devon A Lawson; Elizabeth Sinclair; Chih-Yang Wang; Ming-Derg Lai; Steven W Hetts; Randall T Higashida; Christopher F Dowd; Van V Halbach; Zena Werb; Hua Su; Daniel L Cooke
Journal:  Biotechnol Rep (Amst)       Date:  2015-08-01

6.  Discovery of multi-target receptor tyrosine kinase inhibitors as novel anti-angiogenesis agents.

Authors:  Jinfeng Wang; Lin Zhang; Xiaoyan Pan; Bingling Dai; Ying Sun; Chuansheng Li; Jie Zhang
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

Review 7.  The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.

Authors:  Enming Du; Xue Li; Siyu He; Xiaohua Li; Shikun He
Journal:  Mol Biol Rep       Date:  2020-06-02       Impact factor: 2.316

8.  Shear stress promotes differentiation of stem cells from human exfoliated deciduous teeth into endothelial cells via the downstream pathway of VEGF-Notch signaling.

Authors:  Penglai Wang; Shaoyue Zhu; Changyong Yuan; Lei Wang; Jianguang Xu; Zongxiang Liu
Journal:  Int J Mol Med       Date:  2018-07-06       Impact factor: 4.101

Review 9.  Arteriogenesis of the Spinal Cord-The Network Challenge.

Authors:  Florian Simon; Markus Udo Wagenhäuser; Albert Busch; Hubert Schelzig; Alexander Gombert
Journal:  Cells       Date:  2020-02-22       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.